Cyclic Peptide-Gadolinium Nanoparticles for Enhanced Intracellular Delivery

Amir Nasrolahi Shirazi1, Shang Eun Park2, Shirin Rad1

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, Marshall B. Ketchum University, Fullerton, CA 92831, USA.

Pharmaceutics
|August 23, 2020
PubMed
Summary

Researchers synthesized gadolinium nanoparticles using a cyclic peptide [(WR)5C]. These peptide-Gd nanoparticles enhance cellular uptake and drug delivery, showing potential as a non-toxic MRI contrast agent for targeted cancer therapy.

Related Concept Videos